Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: Patent Law
Federal Circuit Will Review Cybor Decision En Banc
On March 15th, in a long-awaited ruling, the Fed. Cir. vacated a panel holding reversing a lower court’s finding that disputed means-plus-function claims met the written description requirement. The Fed. Cir. asked the parties and amici (and there will be … Continue reading
Posted in Claim Interpretation
Tagged Cybor, Federal Circuit, KSR, Patent Law, Warren Woessner
Leave a comment
Brilliant Instruments v. GuideTech – Doctrine of Equivalents on Review
Contributed by Theresa Stadheim of Schwegman Lundberg & Woessner In Brilliant Instruments, Inc., v. Guidetech, LLC, Appeal no. 2012-1018 (Fed. Cir. February 20, 2013) (a copy can be found at the end of this post), a panel of the Federal … Continue reading
USPTO Publishes Extensive Examination Guidelines for 35 U.S.C. 102 and 103
On February 14, 2013, the PTO published extensive Examination Guidelines for examination of applications filed after March 16, 2013, under 102 and 103 as amended by the AIA. Given the debates, if not confusion, that arose following the publication of … Continue reading
Posted in AIA Patent Reform, USPTO Practice and Policy
Tagged AIA, intellectual property, Patent Law, USPTO, Warren Woessner
2 Comments
Time For Myriad To Fight Another Day
Put another way, it is time for Jones Day to click their well-polished heels and go home. Today, the U.S. Government filed an amicus brief largely supporting the arguments by AMP/ACLU that isolated DNA is essentially the same molecule after … Continue reading